A detailed history of Geode Capital Management, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,644,039 shares of CDXS stock, worth $8.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,644,039
Previous 1,632,957 0.68%
Holding current value
$8.53 Million
Previous $5.06 Million 0.02%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.62 - $3.71 $29,034 - $41,114
11,082 Added 0.68%
1,644,039 $5.06 Million
Q2 2024

Aug 09, 2024

BUY
$2.65 - $3.92 $186,236 - $275,489
70,278 Added 4.5%
1,632,957 $5.06 Million
Q1 2024

May 13, 2024

BUY
$2.59 - $4.65 $125,063 - $224,534
48,287 Added 3.19%
1,562,679 $5.45 Million
Q4 2023

Feb 13, 2024

BUY
$1.54 - $3.37 $186,725 - $408,612
121,250 Added 8.7%
1,514,392 $4.62 Million
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.75 $76,258 - $190,646
50,839 Added 3.79%
1,393,142 $2.63 Million
Q2 2023

Aug 11, 2023

BUY
$2.21 - $4.43 $245,336 - $491,783
111,012 Added 9.02%
1,342,303 $3.76 Million
Q1 2023

May 15, 2023

BUY
$3.81 - $6.76 $157,543 - $279,526
41,350 Added 3.47%
1,231,291 $5.1 Million
Q4 2022

Feb 13, 2023

BUY
$4.26 - $6.84 $278,467 - $447,117
65,368 Added 5.81%
1,189,941 $5.55 Million
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $402,256 - $853,633
66,379 Added 6.27%
1,124,573 $6.81 Million
Q2 2022

Aug 12, 2022

SELL
$8.35 - $21.89 $233,324 - $611,672
-27,943 Reduced 2.57%
1,058,194 $11.1 Million
Q1 2022

May 13, 2022

BUY
$16.97 - $31.93 $704,679 - $1.33 Million
41,525 Added 3.98%
1,086,137 $22.4 Million
Q4 2021

Feb 11, 2022

BUY
$25.61 - $41.78 $1.07 Million - $1.74 Million
41,662 Added 4.15%
1,044,612 $32.7 Million
Q3 2021

Nov 12, 2021

BUY
$19.65 - $27.99 $51,581 - $73,473
2,625 Added 0.26%
1,002,950 $23.3 Million
Q2 2021

Aug 13, 2021

BUY
$17.48 - $25.46 $1.11 Million - $1.61 Million
63,272 Added 6.75%
1,000,325 $22.7 Million
Q1 2021

May 12, 2021

BUY
$18.08 - $28.8 $1.23 Million - $1.97 Million
68,282 Added 7.86%
937,053 $21.4 Million
Q4 2020

Feb 12, 2021

BUY
$11.7 - $23.41 $1.05 Million - $2.11 Million
90,121 Added 11.57%
868,771 $19 Million
Q3 2020

Nov 13, 2020

BUY
$11.21 - $13.82 $112,806 - $139,070
10,063 Added 1.31%
778,650 $9.14 Million
Q2 2020

Aug 13, 2020

BUY
$9.8 - $12.77 $250,292 - $326,145
25,540 Added 3.44%
768,587 $8.76 Million
Q1 2020

May 14, 2020

BUY
$8.78 - $18.6 $461,582 - $977,839
52,572 Added 7.61%
743,047 $8.29 Million
Q4 2019

Feb 13, 2020

BUY
$13.12 - $17.06 $295,895 - $384,754
22,553 Added 3.38%
690,475 $11 Million
Q3 2019

Nov 12, 2019

BUY
$12.75 - $19.01 $274,660 - $409,513
21,542 Added 3.33%
667,922 $9.16 Million
Q2 2019

Aug 14, 2019

BUY
$17.0 - $21.88 $961,078 - $1.24 Million
56,534 Added 9.58%
646,380 $11.9 Million
Q1 2019

May 14, 2019

BUY
$15.53 - $22.15 $363,137 - $517,933
23,383 Added 4.13%
589,846 $12.1 Million
Q4 2018

Feb 13, 2019

BUY
$14.06 - $22.57 $144,663 - $232,222
10,289 Added 1.85%
566,463 $9.46 Million
Q3 2018

Nov 13, 2018

BUY
$13.35 - $19.1 $1.15 Million - $1.64 Million
85,898 Added 18.27%
556,174 $9.54 Million
Q2 2018

Aug 14, 2018

BUY
$10.35 - $16.45 $705,932 - $1.12 Million
68,206 Added 16.96%
470,276 $6.77 Million
Q1 2018

May 15, 2018

BUY
$8.0 - $12.8 $549,312 - $878,899
68,664 Added 20.59%
402,070 $4.42 Million
Q4 2017

Feb 13, 2018

BUY
$5.85 - $8.4 $166,461 - $239,022
28,455 Added 9.33%
333,406 $2.78 Million
Q3 2017

Nov 14, 2017

BUY
$4.9 - $6.65 $68,747 - $93,299
14,030 Added 4.82%
304,951 $2.03 Million
Q2 2017

Aug 14, 2017

BUY
N/A
290,921
290,921 $1.59 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $340M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.